Previous close | 161.33 |
Open | 161.33 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 161.33 - 161.33 |
52-week range | 111.91 - 161.33 |
Volume | |
Avg. volume | 25 |
Market cap | 38.461B |
Beta (5Y monthly) | 0.26 |
PE ratio (TTM) | 37.00 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.24 (1.39%) |
Ex-dividend date | 10 May 2024 |
1y target est | N/A |
WALTHAM, Mass., April 17, 2024--The Wolters Kluwer Health Regulatory Audit Module helps mitigate Risk Adjustment Data Validation (RADV) audits and extrapolation.
NEW YORK, April 17, 2024--Wolters Kluwer, a global leader in information, software, and services for professionals, today announced Atul Dubey as General Manager of its Finance, Risk and Regulatory Reporting (FRR) business, part of its Corporate Performance & ESG (CP & ESG) division. Suzanne Konstance will succeed Dubey as General Manager of Wolters Kluwer Legal & Regulatory U.S, part of the company’s Legal & Regulatory division, effective May 1.
WALTHAM, Mass., April 16, 2024--A Wolters Kluwer Health survey finds 68% of U.S. physicians changed views in the last year, now more likely view GenAI as beneficial to healthcare.